Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the fourth quarter and full year ended December 31, 2025.

Q4 2025 Management View Marc Casper, Chairman, President & CEO, emphasized, "We delivered a strong year, capped off by an ...

Thermo Fisher Scientific on Thursday beat Wall Street estimates for fourth-quarter profit and revenue on strong demand for ...

Thusday morning, Thermo Fisher Scientific, which has a laboratory in Center Valley and also an Allentown location, reported ...

Life sciences company Thermo Fisher (NYSE:TMO) reported Q4 CY2025 results , with sales up 7.2% year on year to $12.22 billion ...

Thermo Fisher beat Q4 earnings and revenue estimates, driven by life sciences growth, and forecast 4%–6% revenue growth with ...

Thermo Fisher Scientific has received a total of 8 ratings from analysts, with the consensus rating as Buy. With an average ...

Thermo Fisher Scientific: recent gains put performance in focus Thermo Fisher Scientific (TMO) has drawn investor attention ...

Thermo Fisher and NVIDIA collaborate to integrate AI into scientific research, enhancing laboratory automation and efficiency. Thermo Fisher Scientific has entered a strategic collaboration with ...

The large laboratory equipment supplier had grown its Western North Carolina site during the pandemic.

Q4 2025 Earnings Call January 29, 2026 8:30 AM EST Good morning, ladies and gentlemen, and welcome to the Thermo Fisher Scientific 2025 Fourth Quarter Conference Call. [Operator Instructions] I would ...

The DXR3 SmartRaman+ Spectrometeris an at-line Raman spectrometer designed for pharmaceutical quality control.